Nayelli C Flores-Garcia
Overview
Explore the profile of Nayelli C Flores-Garcia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flores-Garcia N, Dirac M, Han H, Kershenobich-Stalnikowitz D
Gac Med Mex
. 2024 Feb;
159(6):494-501.
PMID: 38386880
Background: Liver cirrhosis is a major cause of morbidity and mortality worldwide. In Mexico, it is one of the six leading causes of death. Objective: To analyze epidemiological data derived...
2.
Ruiz-Margain A, Macias-Rodriguez R, Flores-Garcia N, Roman Calleja B, Fierro-Angulo O, Gonzalez-Regueiro J
Nutr Clin Pract
. 2023 Dec;
39(1):14-26.
PMID: 38097210
The assessment of nutrition status, sarcopenia, and frailty holds significant relevance in the context of adult transplantation, as these factors are associated with an unfavorable prognosis; thus, transplant candidates must...
3.
Ruiz-Margain A, Pohlmann A, Lanzerath S, Langheinrich M, Campos-Murguia A, Roman-Calleja B, et al.
JHEP Rep
. 2023 Aug;
5(8):100761.
PMID: 37554924
Background & Aims: Acute-on-chronic liver failure (ACLF) has been linked to different pathophysiological mechanisms, including systemic inflammation and mitochondrial dysfunction. Sarcopenia has also been proposed as a potential mechanism; myostatin...
4.
Macias-Rodriguez R, Solis-Ortega A, Ornelas-Arroyo V, Ruiz-Margain A, Gonzalez-Huezo M, Urdiales-Moran N, et al.
World J Gastroenterol
. 2022 Oct;
28(37):5444-5456.
PMID: 36312835
Background: Metabolic associated fatty liver disease (MAFLD) is associated with complications and mortality in patients with coronavirus disease 2019 (COVID-19). However, there are no prognostic scores aimed to evaluate the...
5.
Mayorquin-Aguilar J, Lara-Reyes A, Revuelta-Rodriguez L, Flores-Garcia N, Ruiz-Margain A, Jimenez-Ferreira M, et al.
World J Hepatol
. 2022 Sep;
14(8):1678-1686.
PMID: 36157873
Background: The global coronavirus disease 2019 (COVID-19) pandemic has caused more than 5 million deaths. Multiorganic involvement is well described, including liver disease. In patients with critical COVID-19, a new...
6.
Ruiz-Margain A, Roman-Calleja B, Moreno-Guillen P, Gonzalez-Regueiro J, Kusulas-Delint D, Campos-Murguia A, et al.
World J Gastrointest Oncol
. 2021 Nov;
13(10):1440-1452.
PMID: 34721776
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and presents together with cirrhosis in most cases. In addition to commonly recognized risk factors for HCC development, such as...
7.
Campos-Murguia A, Roman-Calleja B, Gonzalez-Regueiro J, Hurtado-Diaz-de-Leon I, Solis-Ortega A, Flores-Garcia N, et al.
World J Gastroenterol
. 2021 Sep;
27(33):5502-5519.
PMID: 34588748
Metabolic diseases are highly prevalent worldwide and have been associated with adverse clinical outcomes, including mortality, in patients developing coronavirus disease (COVID-19). Because of the close relationship between metabolic diseases...
8.
Kauffman-Ortega E, Ruiz-Manriquez J, Olivas-Martinez A, Campos-Murguia A, Flores-Garcia N, Marquez-Guillen E, et al.
Arch Med Res
. 2021 May;
52(7):713-718.
PMID: 33966917
Background: Hepatitis C virus (HCV) infection is one of the most frequent causes of liver transplantation (LT) worldwide. Patients with HCV viremia at the time of LT universally develop recurrent...
9.
Perez-Gonzalez B, Thomas-Lora F, Hoyo I, Flores-Garcia N, Rodriguez-Aguilar E, Paez-Zayas V, et al.
Cir Cir
. 2021 Mar;
89(2):269-274.
PMID: 33784290
Antecedentes: En diciembre de 2019 se identificó en la ciudad de Wuhan, China, un nuevo beta coronavirus, el SARS-CoV-2, como agente causal de neumonía grave, conocida como COVID-19, lo cual...
10.
Campos-Murguia A, Valdez-Hernandez P, Cordova-Gallardo J, Arteaga-Vazquez J, Contreras A, Vilatoba M, et al.
Clin Res Hepatol Gastroenterol
. 2021 Feb;
45(4):101519.
PMID: 33636655
Introduction: Alpha-1 antitrypsin deficiency (AATD) is a risk factor for liver disease. PASD-positive inclusions have been found unexpectedly in approximately 10% of liver explants in patients with no previous diagnosis...